TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21244446

Group type: EXPERIMENTAL
Intervention: Intra‐articular 70% ethyl alcohol alone (IAEA)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intra‐articular 70% ethyl alcohol in combination with 2 percutaneously placed transarticular lag screws (EA‐TLS)
Number of subjects: 6
Study: 19178123

Group type: EXPERIMENTAL
Intervention: Subcutaneous interferon-beta-1a (SC IFNb1a) administered three times a week
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Intramuscular interferon-beta-1a (IM IFNb1a) administered once a week
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Subcutaneous interferon-beta-1a (SC IFNb1a)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Intramuscular interferon-beta-1a (IM IFNb1a)
Number of subjects: 1000
Study: 17705694

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (1 year administration)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control subjects (no intervention)
Number of subjects: 22
Study: 15800754

Group type: EXPERIMENTAL
Intervention: Midvastus approach
Number of subjects: 21

Group type: COMPARATOR
Intervention: Medial parapatellar approach
Number of subjects: 21
Study: 12481955

Group type: EXPERIMENTAL
Intervention: Traditional acupuncture
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Formula acupuncture
Number of subjects: 593

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 593

Group type: COMPARATOR
Intervention: No acupuncture
Number of subjects: 593
Study: 9579104

Group type: EXPERIMENTAL
Intervention: Single broadband noise signal from a subset of six loudspeakers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presence of pairs of speakers that were symmetrically opposed
Number of subjects: 0
Study: 8620673

Group type: EXPERIMENTAL
Intervention: Zileuton (600mg every 6 hours)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2669904

Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 1191616

Group type: EXPERIMENTAL
Intervention: Electric drill removal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manual removal
Number of subjects: 0
Study: 31317523

Group type: EXPERIMENTAL
Intervention: Therapist‐oriented home rehabilitation (TOHR)
Number of subjects: 17
Study: 27834460

Group type: EXPERIMENTAL
Intervention: Zirconia-on-polyethylene (group A)
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Metal-on-metal (group B)
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Zirconia-on-polyethylene with the liner moulded into the shell (group C)
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Alumina-on-alumina (group D)
Number of subjects: 393
Study: 25670536

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Quinine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dolasetron
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 15

Group type: COMPARATOR
Intervention: Levocetirizine
Number of subjects: 15
Study: 23218821

Group type: EXPERIMENTAL
Intervention: Carotenoids with Coantioxidants (lutein, zeaxanthin, vitamin C, vitamin E, copper, and zinc)
Number of subjects: 433

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 433
Study: 21777702

Group type: EXPERIMENTAL
Intervention: Polypill containing 75 mg aspirin, 40 mg simvastatin, 10 mg lisinopril, and either 12.5 mg hydrochlorothiazide or 50 mg atenolol
Number of subjects: 600

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 600
Study: 19396428

Group type: EXPERIMENTAL
Intervention: Operative treatment (surgical release of the internal obturator tendon)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (non-operative treatment)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Degenerative changes at L3-L5 level
Number of subjects: 12
Study: 17007709

Group type: EXPERIMENTAL
Intervention: Team-based continuous quality improvement (CQI) intervention
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study: 15497363

Group type: EXPERIMENTAL
Intervention: +45 mmHg LBPP
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: -20 mmHg LBNP
Number of subjects: 6

Group type: COMPARATOR
Intervention: No pressure (Control)
Number of subjects: 6
Study: 12823077

Group type: EXPERIMENTAL
Intervention: Fluvoxamine CR (100 to 300 mg once daily for 12 weeks)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo (once daily for 12 weeks)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Fluvoxamine CR
Number of subjects: 253
Study: 10221739

Group type: EXPERIMENTAL
Intervention: Research Assistants (RAs)
Number of subjects: 347

Group type: COMPARATOR
Intervention: Senior Investigators (SI)
Number of subjects: 347
Study: 7784236

Group type: COMPARATOR
Intervention: Conventional treatment (digitalis, diuretics, and vasodilators) for 8.1 +/- 0.7 months (Control)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Conventional therapy plus prednisone
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Conventional therapy plus prednisone and azathioprine
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Conventional therapy plus prednisone and cyclosporine
Number of subjects: 68
Study: 2360388

Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate
Number of subjects: 84

Group type: COMPARATOR
Intervention: Intravenous saline (control)
Number of subjects: 84
Study: 222145

Group type: EXPERIMENTAL
Intervention: Nicotinyl alcohol tartrate (Roniacol)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Clofibrate (Atromid‐S)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Both drugs
Number of subjects: 19
Study: 28662153

Group type: EXPERIMENTAL
Intervention: Daily physiotherapy with progressive knee‐extension strength training (10RM), 3 x 10 repetitions, of the fractured limb using ankle weight cuffs.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Daily physiotherapy without strength training.
Number of subjects: 90
Study: 25844612

Group type: EXPERIMENTAL
Intervention: Clindamycin phosphate 1.2%/BP 3.75% gel
Number of subjects: 498

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 498
Study: 23586591

Group type: EXPERIMENTAL
Intervention: Bifonazole 1% cream for 4 weeks after non-surgical nail ablation with urea 40% paste
Number of subjects: 692

Group type: COMPARATOR
Intervention: Placebo for 4 weeks after non-surgical nail ablation with urea 40% paste
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Bifonazole 1% cream
Number of subjects: 692

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 692
Study: 22005390

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF) patients
Number of subjects: 2865
Study: 19252210

Group type: EXPERIMENTAL
Intervention: Simple rule-of-thumb (RoT) algorithms (3 lbs in 1 day and 5 lbs in 3 days)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Moving average convergence divergence (MACD) algorithm
Number of subjects: 168
Study: 16881474

Group type: EXPERIMENTAL
Intervention: transrectal lidocaine gel
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: quadrant lidocaine injections
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: apex‐only lidocaine injections
Number of subjects: 240

Group type: COMPARATOR
Intervention: no local anesthetic
Number of subjects: 240
Study: 15599319

Group type: EXPERIMENTAL
Intervention: Everolimus 1.5 mg/day
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Everolimus 3 mg/day
Number of subjects: 588

Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF) 2 g/day
Number of subjects: 588
Study: 11728761

Group type: EXPERIMENTAL
Intervention: BiPAP
Number of subjects: 38

Group type: COMPARATOR
Intervention: MASK
Number of subjects: 38
Study: 9205018

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 274

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study: 7957138

Group type: EXPERIMENTAL
Intervention: Squat technique
Number of subjects: 10

Group type: COMPARATOR
Intervention: Stoop technique
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 10
Study: 30061029

Group type: EXPERIMENTAL
Intervention: 3 doses of MenABCWY vaccine (0, 2, 6-month schedule)
Number of subjects: 490

Group type: COMPARATOR
Intervention: Single MenACWY-CRM dose at 2 months and placebo at 0, 6 months (Control group)
Number of subjects: 490
Study: 25139979

Group type: EXPERIMENTAL
Intervention: Parenteral cysteine-HCl (CYS group) at 121 mg/kg/d for ≥7 days
Number of subjects: 38

Group type: COMPARATOR
Intervention: Additional PN amino acids (ISO group)
Number of subjects: 38
Study: 23866315

Group type: EXPERIMENTAL
Intervention: Escitalopram (SSRI), 4-week intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21712498

Group type: COMPARATOR
Intervention: rosuvastatin (10 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: darunavir/ritonavir (600/100 mg twice daily)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination of darunavir/ritonavir and rosuvastatin
Number of subjects: 12
Study: 19716434

Group type: EXPERIMENTAL
Intervention: Transparent retractable extension
Number of subjects: 107

Group type: COMPARATOR
Intervention: Narrow band imaging
Number of subjects: 107
Study: 18279940

Group type: COMPARATOR
Intervention: Intermittent Androgen Deprivation (IAD) therapy with bicalutamide 150 mg once daily in on-phases and no therapy in off-phases (Group A)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Intermittent Androgen Deprivation (IAD) therapy with bicalutamide 150 mg once daily in on-phases and etoricoxib 60 mg once daily in off-phases (Group B)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Group B (IAD with etoricoxib)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study: 15930233

Group type: EXPERIMENTAL
Intervention: Liberal transfusion group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Restrictive transfusion group
Number of subjects: 100
Study: 12538198

Group type: EXPERIMENTAL
Intervention: Incisional local anesthetic infiltration plus postoperative patient‐controlled analgesia (Group A)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia and analgesia (Group B)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Postoperative patient‐controlled analgesia (Group C)
Number of subjects: 114
Study: 11776031

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with cyclophosphamide 300 mg/m2, vincristine 1.4 mg/m2, adriamycin 50 mg/m2, lomustine 50 mg/m2 on day 1, and cisplatin 20 mg/m2 on days 1-5, repeated every 4-6 weeks for 4 cycles, followed by oral ftorafur (FT-207) 600-900 mg/d for 1 year
Number of subjects: 70

Group type: COMPARATOR
Intervention: Surgery only
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with cyclophosphamide, vincristine, adriamycin, lomustine, and cisplatin
Number of subjects: 70
Study: 8858224

Group type: EXPERIMENTAL
Intervention: Insulin infusion (serum free insulin approximately 480 pmol/l)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline infusion (physiological NaCl solution)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Comparison of insulin infusion vs saline infusion
Number of subjects: 15
Study: 1634647

Group type: EXPERIMENTAL
Intervention: Nicoderm (nicotine transdermal system) 14 mg/day applied to upper back
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nicoderm (nicotine transdermal system) 14 mg/day applied to upper outer arm
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nicoderm (nicotine transdermal system) 14 mg/day applied to upper chest
Number of subjects: 12
Study: 6545087

Group type: EXPERIMENTAL
Intervention: Caudal analgesia
Number of subjects: 26

Group type: COMPARATOR
Intervention: Non-caudal group (Control)
Number of subjects: 26
Study: 31002483

Group type: EXPERIMENTAL
Intervention: Mentalization-based group intervention
Number of subjects: 64

Group type: COMPARATOR
Intervention: Delayed treatment
Number of subjects: 64
Study: 29523823

Group type: EXPERIMENTAL
Intervention: QuickOpt
Number of subjects: 392

Group type: COMPARATOR
Intervention: Echocardiographic optimization (control)
Number of subjects: 392
Study: 27388012

Group type: EXPERIMENTAL
Intervention: G6PD heterozygous (type A+)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: G6PD deficient (type A-)
Number of subjects: 301

Group type: COMPARATOR
Intervention: G6PD normal (type B)
Number of subjects: 301
Study: 24973281

Group type: EXPERIMENTAL
Intervention: Lumacaftor 200 mg once daily and ivacaftor 250 mg every 12 h for 14 days followed by 7 days of ivacaftor or 21 days of placebo
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Lumacaftor 400 mg once daily
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Lumacaftor 600 mg once daily
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Lumacaftor 400 mg every 12 h
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study: 22119354

Group type: EXPERIMENTAL
Intervention: gemcitabine plus erlotinib
Number of subjects: 569

Group type: COMPARATOR
Intervention: gemcitabine
Number of subjects: 569
Study: 19229449

Group type: EXPERIMENTAL
Intervention: Low-frequency repetitive transcranial magnetic stimulation (0.5 Hz, 15 min/session, twice a day for 2 weeks)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 14
Study: 17373173

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide (BP) 9% cleanser daily, clindamycin 1% foam daily, doxycycline 100 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Benzoyl peroxide (BP) 9% cleanser daily, doxycycline 100 mg twice daily without clindamycin 1% foam
Number of subjects: 0
Study: 15795602

Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 32

Group type: COMPARATOR
Intervention: Enhanced standard of care
Number of subjects: 32
Study: 11999456

Group type: EXPERIMENTAL
Intervention: Home exercise program (squeezing a ball, 20 times each hand, three times a day, at least three times a week)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Home exercise program
Number of subjects: 16
Study: 9592633

Group type: EXPERIMENTAL
Intervention: Recombinant human IGF‐I (rhIGF‐I) therapy (40‐80 micrograms/kg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8137669

Group type: EXPERIMENTAL
Intervention: 2 liters of polyethylene glycol with bisacodyl
Number of subjects: 382

Group type: COMPARATOR
Intervention: 4 liters of polyethylene glycol
Number of subjects: 382
Study: 2672819

Group type: EXPERIMENTAL
Intervention: Apraclonidine 1%
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Apraclonidine 0.5%
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Apraclonidine (both concentrations)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Apraclonidine
Number of subjects: 32
Study: 788907

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (DHE) 2 mg three times daily for 14 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Before treatment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (DHE)
Number of subjects: 40
Study: 31645199

Group type: EXPERIMENTAL
Intervention: Active rTMS over the right DLPFC for 20 minutes before the DF task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active rTMS over the right DLPFC
Number of subjects: 0
Study: 30531382

Group type: EXPERIMENTAL
Intervention: High-Intensity Multimodal Exercise Boot Camp (HIBC)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Usual Care, Low-Intensity Exercise Program (UC)
Number of subjects: 27
Study: 27938898

Group type: EXPERIMENTAL
Intervention: Blood conservation protocol (2009)
Number of subjects: 890
Study: 26118138

Group type: EXPERIMENTAL
Intervention: Experiences of major discrimination
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Aggregate counts of everyday and major discrimination
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Experience of discrimination in getting care for physical health
Number of subjects: 221
Study: 24013702

Group type: EXPERIMENTAL
Intervention: Deep sedation with propofol, midazolam, and piritramide during AF ablation
Number of subjects: 401
Study: 21337214

Group type: EXPERIMENTAL
Intervention: guided negative rumination condition
Number of subjects: 114

Group type: COMPARATOR
Intervention: distraction condition
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: both conditions (guided negative rumination and distraction)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: socially anxious individuals
Number of subjects: 114
Study: 20019909

Group type: EXPERIMENTAL
Intervention: Cadmium exposure (measured as blood cadmium concentration of 0.21 microg/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cadmium exposure
Number of subjects: 0
Study: 17251531

Group type: EXPERIMENTAL
Intervention: Posaconazole
Number of subjects: 602

Group type: COMPARATOR
Intervention: Fluconazole or Itraconazole
Number of subjects: 602
Study: 15509356

Group type: EXPERIMENTAL
Intervention: Implementation intentions intervention
Number of subjects: 159

Group type: COMPARATOR
Intervention: Non-intervention (control) group
Number of subjects: 159
Study: 11820754

Group type: EXPERIMENTAL
Intervention: Judging spatial relationships at encoding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Judging physical and semantic object attributes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Object identification at encoding
Number of subjects: 0
Study: 9726716

Group type: EXPERIMENTAL
Intervention: Combination therapy with nebulized 2.5 mg salbutamol plus 0.5 mg ipratropium bromide
Number of subjects: 1064

Group type: COMPARATOR
Intervention: Nebulized 2.5 mg salbutamol alone
Number of subjects: 1064
Study: 8061262

Group type: EXPERIMENTAL
Intervention: Propofol-fentanyl anesthesia
Number of subjects: 64

Group type: COMPARATOR
Intervention: Isoflurane-fentanyl anesthesia
Number of subjects: 64
Study: 2493044

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 17

Group type: COMPARATOR
Intervention: Theophylline-terfenadine combination
Number of subjects: 17
Study: 779920

Group type: EXPERIMENTAL
Intervention: 113InmCl3
Number of subjects: 2

Group type: COMPARATOR
Intervention: 125I‐labelled human serum albumin
Number of subjects: 2
Study: 29698015

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 4387

Group type: COMPARATOR
Intervention: Diabetes support and education (DSE; control condition)
Number of subjects: 4387
Study: 26050975

Group type: EXPERIMENTAL
Intervention: Child Support Grant (CSG) receipt duration
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: HIV exposure
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Low birth weight
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Maternal education
Number of subjects: 746
Study: 24077690

Group type: EXPERIMENTAL
Intervention: Systemic tranexamic acid
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Knee flexion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 22866562

Group type: EXPERIMENTAL
Intervention: Canine interaction
Number of subjects: 33

Group type: COMPARATOR
Intervention: Viewing a canine movie (control)
Number of subjects: 33
Study: 21242603

Group type: EXPERIMENTAL
Intervention: jOG intervention
Number of subjects: 42
Study: 17611232

Group type: EXPERIMENTAL
Intervention: Oral co-amoxiclav (50 mg/kg/day in three doses for 10 days)
Number of subjects: 502

Group type: COMPARATOR
Intervention: Parenteral ceftriaxone (50 mg/kg/day in a single parenteral dose for three days) followed by oral co-amoxiclav (50 mg/kg/day in three divided doses for seven days)
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Oral co-amoxiclav
Number of subjects: 502

Group type: COMPARATOR
Intervention: Parenteral ceftriaxone followed by oral co-amoxiclav
Number of subjects: 502
Study: 15627814

Group type: EXPERIMENTAL
Intervention: DRD4 2- or 5-allele polymorphism in men
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: DRD4 2- or 5-allele polymorphism in women
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Novelty Seeking (NS) in men
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Novelty Seeking (NS) in women
Number of subjects: 125
Study: 12162764

Group type: EXPERIMENTAL
Intervention: Cisplatin/epinephrine injectable gel
Number of subjects: 179

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 179
Study: 10480519

Group type: EXPERIMENTAL
Intervention: Obese patients with DKA
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Lean patients with DKA
Number of subjects: 131

Group type: COMPARATOR
Intervention: Obese patients with hyperglycemia
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: All DKA patients with GAD autoantibodies
Number of subjects: 131

Group type: COMPARATOR
Intervention: HLA distribution
Number of subjects: 131
Study: 8916489

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 101
Study: 1674853

Group type: EXPERIMENTAL
Intervention: Ipsapirone, 0.3 mg/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ipsapirone
Number of subjects: 12
Study: 6758747

Group type: EXPERIMENTAL
Intervention: Sodium Heparin
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Calcium Heparin
Number of subjects: 234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study: 31627905

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node (SLN) biopsy
Number of subjects: 0
Study: 31163755

Group type: EXPERIMENTAL
Intervention: MOSMO method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Assigned PA aware SMO
Number of subjects: 0
Study: 28805045

Group type: EXPERIMENTAL
Intervention: IV golimumab at 2 mg/kg
Number of subjects: 480

Group type: COMPARATOR
Intervention: IV placebo
Number of subjects: 480
Study: 27637858

Group type: EXPERIMENTAL
Intervention: Intensity Modulated Radiation Therapy (IMRT)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Standard wedge radiotherapy
Number of subjects: 241